Skip to main content
Download PDF
- Main
High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies.
- Horsburgh, Bethany A;
- Lee, Eunok;
- Hiener, Bonnie;
- Eden, John-Sebastian;
- Schlub, Timothy E;
- von Stockenstrom, Susanne;
- Odevall, Lina;
- Milush, Jeffrey M;
- Liegler, Teri;
- Sinclair, Elizabeth;
- Hoh, Rebecca;
- Boritz, Eli A;
- Douek, Daniel C;
- Fromentin, Remi;
- Chomont, Nicolas;
- Deeks, Steven G;
- Hecht, Frederick M;
- Palmer, Sarah
- et al.
Published Web Location
https://doi.org/10.1097/qad.0000000000002465Abstract
Objective
The contribution of HLA-DR+ memory CD4 T cells to the HIV reservoir during prolonged antiretroviral therapy is unclear as these cells are commonly excluded when assessing for replication-competent HIV. To address this issue, we examined the distribution of genetically intact HIV DNA within HLA-DR- and HLA-DR+ memory CD4 T cells and the RNA transcriptional profile of these cells during antiretroviral therapy.Design/methods
Full-length DNA sequencing was used to examine the HIV DNA landscape within HLA-DR+ and HLA-DR- memory CD4 T cells. RNA quantification and sequencing was used to interrogate the relationship between HLA-DR status and HIV RNA transcription.Results
HLA-DR+ CD4 T cells contained a high frequency of genetically intact HIV genomes, contributing over half of the genetically intact viral sequences to the reservoir. Expansions of genetically identical sequences were identified in all T-cell subsets, indicating that cellular proliferation maintains genetically intact and defective viral DNA during therapy. Intracellular HIV RNA levels in HLA-DR+ and HLA-DR- T cells were not statistically different by either long terminal repeat quantitative PCR quantification or single-genome RNA sequencing of the p6-RT region.Conclusion
The high proportion of intact viral DNA sequences in the proliferative HLA-DR+ subset suggests they are critical in maintaining HIV infection during effective therapy. As such, these cells should be included in any immune intervention targeting HIV during effective therapy.Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%